Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Shenda Baker | M | - |
Synedgen, Inc.
Synedgen, Inc. Pharmaceuticals: MajorHealth Technology Synedgen, Inc. operates as a biotechnology company leveraging a proprietary glycomics technology platform to develop modified therapeutic polysaccharides that target mucosal surfaces in genetic and acquired disorders. The firm’s products include Prisyna oral care and Synedgen wound care. The company was founded by William P. Wiesmann and Shenda Baker in 2009 and is headquartered in Claremont, CA. | 15 years |
William P. Wiesmann | M | - |
Synedgen, Inc.
Synedgen, Inc. Pharmaceuticals: MajorHealth Technology Synedgen, Inc. operates as a biotechnology company leveraging a proprietary glycomics technology platform to develop modified therapeutic polysaccharides that target mucosal surfaces in genetic and acquired disorders. The firm’s products include Prisyna oral care and Synedgen wound care. The company was founded by William P. Wiesmann and Shenda Baker in 2009 and is headquartered in Claremont, CA. | 15 years |
Daniel Bradbury | M | 62 |
Synedgen, Inc.
Synedgen, Inc. Pharmaceuticals: MajorHealth Technology Synedgen, Inc. operates as a biotechnology company leveraging a proprietary glycomics technology platform to develop modified therapeutic polysaccharides that target mucosal surfaces in genetic and acquired disorders. The firm’s products include Prisyna oral care and Synedgen wound care. The company was founded by William P. Wiesmann and Shenda Baker in 2009 and is headquartered in Claremont, CA. | - |
Dennis Fenton | M | 72 |
Synedgen, Inc.
Synedgen, Inc. Pharmaceuticals: MajorHealth Technology Synedgen, Inc. operates as a biotechnology company leveraging a proprietary glycomics technology platform to develop modified therapeutic polysaccharides that target mucosal surfaces in genetic and acquired disorders. The firm’s products include Prisyna oral care and Synedgen wound care. The company was founded by William P. Wiesmann and Shenda Baker in 2009 and is headquartered in Claremont, CA. | 3 years |
Paul Grint | M | 66 |
Synedgen, Inc.
Synedgen, Inc. Pharmaceuticals: MajorHealth Technology Synedgen, Inc. operates as a biotechnology company leveraging a proprietary glycomics technology platform to develop modified therapeutic polysaccharides that target mucosal surfaces in genetic and acquired disorders. The firm’s products include Prisyna oral care and Synedgen wound care. The company was founded by William P. Wiesmann and Shenda Baker in 2009 and is headquartered in Claremont, CA. | 10 years |
Andrew W. Miller | M | - |
Synedgen, Inc.
Synedgen, Inc. Pharmaceuticals: MajorHealth Technology Synedgen, Inc. operates as a biotechnology company leveraging a proprietary glycomics technology platform to develop modified therapeutic polysaccharides that target mucosal surfaces in genetic and acquired disorders. The firm’s products include Prisyna oral care and Synedgen wound care. The company was founded by William P. Wiesmann and Shenda Baker in 2009 and is headquartered in Claremont, CA. | - |
Kenton Gregory | M | - |
Synedgen, Inc.
Synedgen, Inc. Pharmaceuticals: MajorHealth Technology Synedgen, Inc. operates as a biotechnology company leveraging a proprietary glycomics technology platform to develop modified therapeutic polysaccharides that target mucosal surfaces in genetic and acquired disorders. The firm’s products include Prisyna oral care and Synedgen wound care. The company was founded by William P. Wiesmann and Shenda Baker in 2009 and is headquartered in Claremont, CA. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 7 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christopher Ryan
- Personal Network